Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human SSBP2 aa 300 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: P81877
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab177944 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 38 kDa.|
|IHC-P||1/50 - 1/100.|
|Flow Cyt||1/10 - 1/100.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling SSBP2 with ab177944 at 1/50 dilution.
Immunohistochemical analysis of paraffin-embedded Human squamous cell carcinoma tissue labeling SSBP2 with ab177944 at 1/50 dilution.
Flow cytometric analysis of permeabilized Jurkat cells labeling SSBP2 with ab177944 at 1/10 dilution (red) compared to a rabbit IgG negative control (green).
ab177944 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"